Diana 100 100mg/ml 10ml Vial by Military Pharma

Usage

1. Allow the Diana 100 vial to reach room temperature (15–25 °C) before use — this reduces oil viscosity and ensures accurate volume aspiration with a 21-gauge draw needle.
2. Disinfect the vial stopper with a fresh alcohol swab and allow it to air-dry for 10 seconds before inserting the needle, consistent with aseptic injection technique.
3. Draw the calculated volume corresponding to your target dose (e.g. 0.25 ml = 25 mg; 0.50 ml = 50 mg) slowly to minimise air bubble inclusion.
4. Switch to a 23–25 gauge injection needle of appropriate length for intramuscular administration into the chosen muscle group (gluteal is preferred for volumes above 0.5 ml).
5. Administer at a slow, steady rate — the oil vehicle requires a controlled push; rapid injection increases local discomfort and does not alter the depot absorption kinetics.
6. After injection, apply gentle pressure with a sterile swab; do not massage aggressively, as this can disrupt the depot formation and alter the intended release profile.

Warnings

Frequently asked questions

What is the half-life of injectable methandienone in Diana 100 and how does it compare to the oral form?

The plasma half-life of the methandienone parent compound delivered via intramuscular injection is approximately 3–6 hours, consistent with values reported in pharmacokinetic studies using plasma assay methodology. Compared to oral methandienone — which clears rapidly after first-pass hepatic extraction — the injectable depot format produces a higher systemic AUC per unit dose and a later, lower Cmax, translating to a smoother and more sustained serum exposure window.

How does the oil depot in Diana 100 affect the methandienone release profile after injection?

After intramuscular injection, methandienone partitions gradually from the oil vehicle into surrounding interstitial fluid before entering capillary circulation. This depot-mediated absorption phase attenuates the sharp concentration peak associated with oral dosing, producing a flatter serum concentration curve. The result is a reduced peak-to-trough fluctuation across the dosing interval, which is the pharmacokinetic basis for the Long-Acting Formula designation applied to this product.

What injection frequency does the pharmacokinetic profile of Diana 100 support for stable plasma levels?

Given the combined effect of depot absorption delay and a 3–6 hour elimination half-life, once-daily injections are generally sufficient to maintain meaningful plasma methandienone concentrations without the sharp intra-day fluctuations seen with multiple oral doses. Users seeking particularly stable troughs may opt for every-other-day administration at adjusted volumes, leveraging the carry-over depot effect from residual oil-phase compound.

How should Diana 100 10ml vials be stored after opening, and does storage temperature affect the oil formulation?

After the stopper is first punctured, Diana 100 should be stored at room temperature (15–25 °C) away from direct light and moisture; refrigeration is not required and may increase oil viscosity, making aspiration into the syringe more difficult. The vial should be kept upright, and the rubber stopper cleaned with an alcohol swab before each withdrawal. Once opened, use within 28 days and discard any vial showing visible precipitation or particulate matter.

What syringe type and needle gauge are appropriate for withdrawing and injecting Diana 100 at 100mg/ml concentration?

For withdrawal from the vial, a 21-gauge needle is practical — the 100 mg/ml oil solution has manageable viscosity at room temperature, so a finer draw needle is unnecessary and slows filling. For intramuscular injection, a 23–25 gauge needle at appropriate length for the target muscle (typically 1–1.5 inches for gluteal injection) delivers the oil safely while minimising injection-site discomfort. Warming the vial briefly in warm water eases aspiration if ambient temperature is low. (2) angle_used

Manufacturer

Military Pharma's certification and manufacturing standards for Diana 100 are structured around two distinct regulatory frameworks applied in sequence: GMP (Good Manufacturing Practice) compliance governs the sterile fill-and-finish environment — cleanroom air classification, equipment qualification, and personnel gowning protocols — while ISO-aligned analytical standards govern the quality-control laboratory through which each batch passes before release authorisation is issued. For an injectable oil preparation at 100 mg/ml, these two frameworks address different failure modes: GMP controls contamination and process consistency during manufacture; the laboratory certification framework ensures that the HPLC potency assay and LAL endotoxin test yielding the batch release data are performed on calibrated, validated instruments against certified reference standards. Military Pharma subjects Diana 100 finished vials to both checkpoints — HPLC quantification of methandienone concentration and LAL endotoxin screening — before any batch enters distribution. The declared 100 mg/ml label claim is therefore a measurement output, not a nominal assumption, a distinction that is pharmacokinetically material: accurate concentration data is the prerequisite for any meaningful calculation of injected dose and expected plasma exposure.